National Pharmaceutical Pricing Authority (NPPA) has asked hospitals to display revised price list of cardiac stents. In a notification, the authority said that state drug controllers have also been sensitised on this issue and will inspect more hospitals in the coming days to check the compliance with its price cap order issued last week.<br/><br/>The authority has cut prices of life-saving coronary stents by up to 85 per cent by capping them at 7,260 rupees for bare metal and 29,600 rupees for drug eluting variety. NPPA has warned stent manufacturers and importers against shortage and said the companies were under legal obligation to maintain smooth production and supply of coronary stents. <br/><br/>The authority has said, if there is any non-availability or withdrawal of stents it should inform to NPPA immediately. A coronary stent is a tube-shaped device placed in the arteries that supply blood to the heart. It keeps the arteries open in the treatment of coronary heart diseases.